Clinical trial
Common Safety Follow-up Trial of Tecemotide (L-BLP25)
NCT01423760
Study timeline
Study start (unknown)2012-01-01Date precision: month
Registry last updated2016-10-06
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non-Small Cell Lung Cancerunresolved
Multiple Myelomaunresolved
Interventions
TecemotideBIOLOGICAL
No interventionOTHER
Sponsors & collaborators
Merck KGaA, Darmstadt, Germanylead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01423760 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.